Records containing: Pulmonary Sarcoidosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-06-04A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
-
CLINICAL_TRIALS study record update · 2026-04-24Role of Genetic Factors in the Pathogenesis of Lung Disease
-
CLINICAL_TRIALS study record update · 2025-12-12A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of a 12-week Administration of OATD-01, an Oral Inhibitor of Chitinase-1 (CHIT1), for the Treatment of Active Pulmonary Sarcoidosis (the KITE Study)
-
CLINICAL_TRIALS study record update · 2025-11-25A Seamless, Phase 1b/2 Multiple Ascending Dose/Proof of Concept Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations
-
CLINICAL_TRIALS study record update · 2025-07-09A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-20A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
-
CLINICAL_TRIALS study record update · 2025-03-03Prospective Randomized Controlled Study Comparing Diagnostic Yield of Endobronchial Cryo Biopsy vs Forceps Biopsy in Patients Undergoing Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for Suspected Sarcoidosis
-
CLINICAL_TRIALS study record update · 2024-11-25PET/CT Study of Biodistribution and Performance of the [68Ga]Ga-DOTA-Siglec-9 in Patients With Rheumatoid Arthritis,Vasculitis or Pulmonary Sarcoidosis, and Radiation Dosimetry, Pharmacokinetics, Biodistribution, Safety and Tolerability in Healthy Men
-
CLINICAL_TRIALS study record update · 2024-10-15Comparison of the Effects of One-Legged and Two-Legged Exercise Training on Exercise Capacity and Fatigue in Patients With Sarcoidosis
-
CLINICAL_TRIALS study record update · 2024-10-02A Subject and Investigator Blinded, Randomized, Placebo-controlled, Repeat-dose, Multicenter Study to Investigate Efficacy, Safety, and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis
-
CLINICAL_TRIALS study record update · 2023-11-02Retrospective Multicenter Case-control Study Comparing Chronic Beryllium Disease to Pulmonary Sarcoidosis
-
CLINICAL_TRIALS study record update · 2023-07-18A Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of Intravenous ATYR1923 in Patients With Pulmonary Sarcoidosis
-
CLINICAL_TRIALS study record update · 2023-06-18CASPA (CArdiac Sarcoidosis in PApworth): Improving the Diagnosis of Cardiac Disease in Patients With Pulmonary Sarcoidosis
-
CLINICAL_TRIALS study record update · 2022-05-31The Effect of Inspiratory Muscle Training and Breathing Exercises Combined With Upper Extremity and Trunk in Patients With Sarcoidosis
-
CLINICAL_TRIALS study record update · 2022-02-21Randomized Controlled Trial Testing the Effect of Hydroxychloroquine Combined With Low-dose Corticosteroid Therapy in Pulmonary Sarcoidosis
-
CLINICAL_TRIALS study record update · 2021-11-08Modulation of Pulmonary Sarcoidosis by Nicotinic Acetylcholine Receptors
-
CLINICAL_TRIALS study record update · 2021-11-02Non-invasive Profiling of Breath Volatile Organic Compounds in Sarcoidosis: Relation to the Lung Microbiome and Markers of Disease Progression.
-
CLINICAL_TRIALS study record update · 2020-03-16A Multiple-dose, Subject and Investigator Blinded, Placebo-controlled, Parallel Design Study to Assess the Efficacy, Safety and Tolerability of ACZ885(Canakinumab) in Patients With Pulmonary Sarcoidosis
-
CLINICAL_TRIALS study record update · 2020-01-06A PHASE 2 RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, 20-WEEK SAFETY, TOLERABILITY, AND EFFICACY STUDY OF PD 0360324 IN ADULT SUBJECTS WITH CHRONIC PULMONARY SARCOIDOSIS
-
CLINICAL_TRIALS study record update · 2018-06-18Mycophenolate for Pulmonary Sarcoidosis
-
CLINICAL_TRIALS study record update · 2016-07-26The Effect of an Oral Antioxidant, N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis
-
CLINICAL_TRIALS study record update · 2016-07-06Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis
-
CLINICAL_TRIALS study record update · 2015-12-08ACTHAR Gel for Chronic Pulmonary Sarcoidosis (ACPS)
-
CLINICAL_TRIALS study record update · 2015-04-09ClinicalTrials.gov study NCT01384123
-
CLINICAL_TRIALS study record update · 2014-07-25Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS). A Multicenter, Prospective, Controlled, Randomized Trial.